Pharmacological aspects of N-acetyl-5-methoxytryptamine (melatonin) and 6-methoxy-1,2,3,4-tetrahydro-β-carboline (pinoline) as antioxidants: Reduction of oxidative damage in brain region homogenates

Journal of Pineal Research

Volumn 26, Issue 4, 1999, Pages 236-246

  Pless, Gitte ^a   Frederiksen, Tina J P ^a   Garcia, Joaquin J ^c   Reiter, Russel J ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Univ of Texas Hlth S C at S A ^*  (United States)

^c NONE

Author keywords

Antioxidants; Cerebellum; Cerebral cortex; H2O2 hypothalamus; Hippocampus; Lipid peroxidation; Melatonin; Oxidative brain damage; Pinoline; Striatum

Indexed keywords

ANTIOXIDANT; MELATONIN; MONOAMINE OXIDASE INHIBITOR; PINOLINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN HOMOGENATE; BRAIN PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT;

ANIMALS; ANTIOXIDANTS; BRAIN; CARBOLINES; DRUG INTERACTIONS; HYDROGEN PEROXIDE; INHIBITORY CONCENTRATION 50; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MELATONIN; RATS; RATS, SPRAGUE-DAWLEY; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TISSUE EXTRACTS;

EID: 0032913239     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-079X.1999.tb00589.x     Document Type: Article

References (42)

1. ARAKSINEN, M.M., B.T. HO, R. AN, D. TAYLER (1978) Major pharmacological effects of 6-methoxytetrahydro-β-carboline, a drug elevating the tissue 5-hydroxytryptamine level. Arzneim.-Forsch./Drug Res. 28:42-46.
2. BARCHAS, J., F. DACOSTA, S. SPECTOR (1967) Acute pharmacology of melatonin. Nature 214:919-920.
3. BERENBAUM, M.C. (1977) Synergy, additivism and antagonism in immunosuppression. Clin. Exp. Immunol. 28:1-18.
4. BRADFORD, M. (1976) A rapid and sensitive method for quantification of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:171-178.
5. CAGNOLI, C.M., C. ATABAY, E. KHARLAMOVA, H. MANEV (1995) Melatonin protects neurons from singlet oxygen-induced apoptosis. J. Pineal Res. 18:222-226.
6. COSTA, E.J.X., R.H. LOPEZ, M.T. LAMY-FREUND (1995) Permeability of pure lipid bilayers to melatonin. J. Pineal. Res. 19:123-126.
7. CUZZOCREA, S., B. ZlNGARELLI, P. GILARD, P. HAKE, A.L. SALZMAN, C. SZABO (1997) Protective effect of melatonin in carrageenan induced models of local inflammation. J. Pineal Res. 23:106-116.
8. CUZZOCREA, S., B. ZINGARELLI, G. COSTANTINO, A.P. CAPUTI (1998) Protective effect of melatonin in a non-septic shock model induced by zymosan in the rat. J. Pineal Res. 25:24-33.
9. DE LA LASTRA, C.A., J. CABERZA, V. MOTILVA, M.F. MAKTIN (1997) Melatonin protects against ischemia-reperfusion injury in rats. J. Pineal Res. 23:47-52.
10. 2-induced lipid peroxidation in rat brain homogenates. Neuroendocrinol. Lett. 19:117-123.
11. GANONG, W.F. (1993) Review of Medical Physiology. 16th Ed. Prentice Hall International, Englewood Cliffs, NJ.
12. GILAD, E., S. CUZZOCREA, B. ZIGANELLI, A.L. SALZMAN, C. SZABO (1997) Melatonin is a scavenger of peroxynitrite. Life Sci. 60:169-174.
13. GIUSTI, P., D. FRANCESCHINI, M. PETRONE, H. MANEV, M. FLOREANI (1996) In vitro and in vivo protection against kainate-induced excitotoxicity by melatonin. J. Pineal Res. 20:226-232.
14. GÖTZ, M.E., G. KÖNIG, P. RIEDERER, M.B.H. YOUDIM (1994) Oxidative stress: Free radical production in neural degeneration. Pharmacol. Ther. 63:37-122.
15. KAWASHIMA, Y., A. HORIGUCHI, M. TAGUCHI, Y. TUYUKI, Y. KARASAWA, H. ARAKI, K. HATAYAMA (1995) Synthesis and pharmacological evaluation of I,2,3,4-tetra-hydro-β-carboline derivatives. Chem. Pharmaccut. Bull. 43:783-787.
16. KEDZIORA, J., G. BARTOSZ (1988) Down's syndrome: A pathology involving the lack of balance of reactive oxygen species. Free Radical Biol. Med. 4:317-330.
17. KOMULAINEN, H., J. TUOMISTO, M.M. AIRAKSINEN, I. KARI, P. PEURA, L. POLLARI (1980) Tetrahydro-β-carbolines and corresponding tryptamines: In vitro inhibition of serotonin, dopamine and noradrenaline in uptake in rat brain synaptosomes. Acta Pharmacol. Toxicol. 46:299-307.
18. 3H]Imipramine recognition site. Eur. J. Pharmacol. 102:379-380.
19. LEINO, M. (1984) 6-Methoxy-tetrahydro-β-carboline and melatonin in human retina. Exp. Eye Res. 38:325-330.
20. LEZOUALC'H, F., T. SKUTELLA, M. WIDMANN, C. BEHL (1996) Melatonin prevents oxidative stress-induced death in hippocampal cells. NeuroReport 7:2071-2077.
21. LI, Z.R., R.J. REITER, O. FUJIMORI, C.S. OH, Y.P. DUAN (1997) Cataractogenesis and lipid peroxidation in newborn rats treated with buthionine sulfoxamine: Preventive actions of melatonin. J. Pineal. Res. 22:117-123.
22. MELCHIORRI, D., R.J. REITER, E. SEWERYNEK, L.D. CHEN, G. NISTICÓ (1995) Melatonin reduces kainate-induced lipid peroxidation of different brain regions. FASEB J. 9:1205-1210.
23. MENENDEZ-PELAEZ, A., B. POEGGELER, R.J. REITER, L. BARLOW-WALDEN, M.I. PABLOS, D-X. TAN (1993) Nuclear localization of melatonin in different mammalian tissues: Immunocytochemical and radioimmunoassay evidence. J. Cell. Biochem. 53:373-382.
24. PÄHKLA, R., J. HARRO, L. RÄGO (1996) Behavioral effects of pinoline in the rat forced swimming open field and elevated plus-maze tests. Pharmacol. Res. 34:73-78.
25. 3H] citalopram. Pharmacol. Toxicol. 80:122-126.
26. PÄHKLA, R., M. ZILMER, T. KULLISAAR, L. RÄGO (1998) Comparison of the antioxidative activity of melatonin and pinoline in vitro. J. Pineal Res. 24:96-101.
27. PAPPOLLA, M.A., M. SOS, R.A. OMAR, R.J. BICK, D.L.M. HICKSON-BICK, R.J. REITER, S. EFTHIMIOPOULOS, N.K. ROBAKIS (1997) Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J. Neurosci. 17:1683-1690.
28. PIERI, C., M. MARRA, F. MORONI, R. RECCHIONI, F. MARCHESELLI (1994) Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci. 55:PL271-PL276.
29. PRINC, F.G., A.A. SUKNAT, A.G. MAXIT, C. CARDALDA, A. BATLLE (1997) Melatonin's antioxidant protection against δ-aminolevulenic acid-induced oxidative damage in rat cerebellum. J. Pineal Res. 23:40-46.
30. REITER, RJ. (1995a) Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 9:526-533.
31. REITER, R.J. (1995b) Antioxidant actions of melatonin. Adv. Pharmacol. 38:103-117.
32. REITER, R.J. (1998) Oxidative damage in the central nervous system: protection by melatonin. Prog. Neurobiol. 56:359-384.
33. REITER, R.J., D. MELCHIORRI, E. SEWERYNEK, B. POEGGELER, C.R. BARLOW-WALDEN, S.H. CHANG, G.G. ORTIZ, D. ACÚNA-CASTROVEJO (1995) A review of the evidence supporting melatonin's role as an antioxidant. J. Pineal Res. 18:1-11.
34. REITER, R.J., L. TANG, J.J. GARCIA, A. MUÑOZ-HOYOS (1997) Pharmalogical actions of melatonin in oxygen radical pathophysiology. Life Sci. 60:2225-2271.
35. RlMON, R., M.M. AlRAKSINEN, I. KARI, J. GYNTHER, E. VENÄLÄINEN, L. HEIKKILÄ, J. RYYPPO, J. PALO (1984) Pinoline, a β-carboline derivative in the serum and cerebrospinal fluid of patients with schizophrenia. Ann. Clin. Res. 16:171-175.
36. SIESJO, B.K. (1992) Pathophysiology and treatment of focal cerebral ischemia. Part 11: Mechanisms of damage and treatment. J. Neurosurg. 77:337-354.
37. 2-induced lipid peroxidation in homogenates of different rat brain regions. J. Pineal Res. 19:51-56.
38. SHIDA, C.S., A.M.L. CASTRUCCI, M.T. LAMY-FREUND (1994) High melatonin solubility in aqueous medium. J. Pineal Res. 16:198-201.
39. STASICA, P., P. ULANSKI, J.M. ROSIAK (1998) Melatonin as a hydroxyl radical scavenger. J. Pineal Res. 25:65-66.
40. TAN, D-X., L-D. CHEN, B. POEGGELER, L.C. MANCHESTER, R.J. REITER (1993) Melatonin: A potent, endogenous hydroxyl radical scavenger. Endocr. J. 1:57-60.
41. TSUCHIYA, H., K. YAMADA, S. OHTANI, N. TAKAGI, H. TODORIKI, T. HAYASHI (1995) Determination of tetrahydro-β-carbolines in rat brain by gas chromatography-negative-ion chemical ionization mass spectrometry without interference from artifactual formation. J. Neurosci. Meth. 62:37-41.
42. YAMAMOTO, H.A., H.W. TANG (1996) Melatonin alleviates L-cysteine-induced seizures and lipid peroxidation in the brain of mice. J. Pineal Res. 21:113-118.